Literature DB >> 30391471

MEK Inhibitor Reverses Metaplasia and Allows Re-Emergence of Normal Lineages in Helicobacter pylori-Infected Gerbils.

Qing Yang1, Tomohiko Yasuda2, Eunyoung Choi3, Takeshi Toyoda4, Joseph T Roland3, Eiji Uchida5, Hiroshi Yoshida5, Yasuyuki Seto6, James R Goldenring7, Sachiyo Nomura8.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 30391471      PMCID： PMC6368860          DOI： 10.1053/j.gastro.2018.10.049

Source DB:  PubMed          Journal:  Gastroenterology        ISSN： 0016-5085            Impact factor:   22.682


× No keyword cloud information.
  15 in total

1.  Spasmolytic polypeptide-expressing metaplasia and intestinal metaplasia: time for reevaluation of metaplasias and the origins of gastric cancer.

Authors:  James R Goldenring; Ki Taek Nam; Timothy C Wang; Jason C Mills; Nicholas A Wright
Journal:  Gastroenterology       Date:  2010-05-05       Impact factor: 22.682

2.  Management of Helicobacter pylori infection-the Maastricht V/Florence Consensus Report.

Authors:  P Malfertheiner; F Megraud; C A O'Morain; J P Gisbert; E J Kuipers; A T Axon; F Bazzoli; A Gasbarrini; J Atherton; D Y Graham; R Hunt; P Moayyedi; T Rokkas; M Rugge; M Selgrad; S Suerbaum; K Sugano; E M El-Omar
Journal:  Gut       Date:  2016-10-05       Impact factor: 23.059

3.  Changes in endoscopic findings of gastritis after cure of H. pylori infection: multicenter prospective trial.

Authors:  Mototsugu Kato; Shuichi Terao; Kyoichi Adachi; Shigemi Nakajima; Takashi Ando; Norimasa Yoshida; Noriya Uedo; Kazunari Murakami; Shuichi Ohara; Masanori Ito; Naomi Uemura; Takuro Shimbo; Hidenobu Watanabe; Takahiro Kato; Kazunori Ida
Journal:  Dig Endosc       Date:  2012-11-08       Impact factor: 7.559

4.  Disruption of nitric oxide signaling by Helicobacter pylori results in enhanced inflammation by inhibition of heme oxygenase-1.

Authors:  Alain P Gobert; Mohammad Asim; M Blanca Piazuelo; Thomas Verriere; Brooks P Scull; Thibaut de Sablet; Ashley Glumac; Nuruddeen D Lewis; Pelayo Correa; Richard M Peek; Rupesh Chaturvedi; Keith T Wilson
Journal:  J Immunol       Date:  2011-10-10       Impact factor: 5.422

5.  Molecular analysis of gastric cancer identifies subtypes associated with distinct clinical outcomes.

Authors:  Razvan Cristescu; Jeeyun Lee; Michael Nebozhyn; Kyoung-Mee Kim; Jason C Ting; Swee Seong Wong; Jiangang Liu; Yong Gang Yue; Jian Wang; Kun Yu; Xiang S Ye; In-Gu Do; Shawn Liu; Lara Gong; Jake Fu; Jason Gang Jin; Min Gew Choi; Tae Sung Sohn; Joon Ho Lee; Jae Moon Bae; Seung Tae Kim; Se Hoon Park; Insuk Sohn; Sin-Ho Jung; Patrick Tan; Ronghua Chen; James Hardwick; Won Ki Kang; Mark Ayers; Dai Hongyue; Christoph Reinhard; Andrey Loboda; Sung Kim; Amit Aggarwal
Journal:  Nat Med       Date:  2015-04-20       Impact factor: 53.440

6.  Helicobacter pylori Therapy for the Prevention of Metachronous Gastric Cancer.

Authors:  Il Ju Choi; Myeong-Cherl Kook; Young-Il Kim; Soo-Jeong Cho; Jong Yeul Lee; Chan Gyoo Kim; Boram Park; Byung-Ho Nam
Journal:  N Engl J Med       Date:  2018-03-22       Impact factor: 91.245

7.  Long-term follow-up after endoscopic resection of gastric superficial neoplastic lesions in Portugal.

Authors:  Pedro Pimentel-Nunes; Francisco Mourão; Nuno Veloso; Luís Pedro Afonso; Manuel Jácome; Luís Moreira-Dias; Mário Dinis-Ribeiro
Journal:  Endoscopy       Date:  2014-07-14       Impact factor: 10.093

8.  Expression of Activated Ras in Gastric Chief Cells of Mice Leads to the Full Spectrum of Metaplastic Lineage Transitions.

Authors:  Eunyoung Choi; Audrey M Hendley; Jennifer M Bailey; Steven D Leach; James R Goldenring
Journal:  Gastroenterology       Date:  2015-12-08       Impact factor: 22.682

Review 9.  Association Between Helicobacter pylori Eradication and Gastric Cancer Incidence: A Systematic Review and Meta-analysis.

Authors:  Yi-Chia Lee; Tsung-Hsien Chiang; Chu-Kuang Chou; Yu-Kang Tu; Wei-Chih Liao; Ming-Shiang Wu; David Y Graham
Journal:  Gastroenterology       Date:  2016-02-02       Impact factor: 22.682

10.  Comprehensive molecular characterization of gastric adenocarcinoma.

Authors: 
Journal:  Nature       Date:  2014-07-23       Impact factor: 49.962
View more
  3 in total

1.  Trop2 is upregulated in the transition to dysplasia in the metaplastic gastric mucosa.

Authors:  Katherine M Riera; Bogun Jang; Jimin Min; Joseph T Roland; Qing Yang; William T Fesmire; Sophie Camilleri-Broet; Lorenzo Ferri; Woo H Kim; Eunyoung Choi; James R Goldenring
Journal:  J Pathol       Date:  2020-06-15       Impact factor: 7.996

Review 2.  Cellular Plasticity, Reprogramming, and Regeneration: Metaplasia in the Stomach and Beyond.

Authors:  James R Goldenring; Jason C Mills
Journal:  Gastroenterology       Date:  2021-10-30       Impact factor: 22.682

3.  Heterogeneity and dynamics of active Kras-induced dysplastic lineages from mouse corpus stomach.

Authors:  Jimin Min; Paige N Vega; Amy C Engevik; Janice A Williams; Qing Yang; Loraine M Patterson; Alan J Simmons; R Jarrett Bliton; Joshua W Betts; Ken S Lau; Scott T Magness; James R Goldenring; Eunyoung Choi
Journal:  Nat Commun       Date:  2019-12-05       Impact factor: 14.919
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.